ACCENDRA HEALTH INC/VA/ Income Statement
ACH|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
ACCENDRA HEALTH INC/VA/ reported $2.8B in revenue and $1.1B in net loss for FY2025. Revenue has declined at a 7.3% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.7B | $2.6B | $10.0B | $9.2B | $8.5B | $9.4B | $9.4B | $9.3B | $9.7B | $9.8B | $8.9B | $8.6B | $8.9B | $8.0B |
| Cost of Revenue | $1.5B | $1.4B | $1.3B | $8.1B | $8.1B | $7.2B | $8.3B | $8.3B | $8.1B | $8.5B | $8.6B | $7.9B | $7.8B | $7.9B | $7.2B |
| Gross Profit | - | $2.2B | $2.1B | $1.8B | $1.1B | $1.3B | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $924.7M | $857.5M | $924.7M | $814.4M |
| SG&A Expense | $1.1B | $1.1B | $1.0B | $1.6B | $1.0B | $1.0B | $952.9M | $952.9M | $1.0B | $970.4M | $993.8M | $682.6M | $610.7M | $682.6M | $592.3M |
| R&D Expense | - | $13.0M | $13.0M | $12.0M | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | $27.5M | -$217.7M | $133.2M | $142.9M | $73.2M | $204.1M | -$352.3M | -$352.3M | $89.3M | $199.6M | $200.4M | $196.8M | $203.5M | $196.8M | $201.3M |
| Interest Expense | $107.2M | $107.6M | $116.8M | $128.9M | $98.1M | $83.4M | $71.0M | $71.0M | $31.8M | $27.1M | $27.1M | $13.4M | $13.7M | $13.4M | $13.0M |
| Income Tax | $729.0K | $20.9M | $6.4M | -$11.5M | -$6.1M | $21.8M | -$32.4M | -$32.4M | -$15.3M | $63.8M | $69.8M | $74.4M | $74.6M | $74.4M | $71.4M |
| Net Income | -$1.1B | -$362.7M | -$41.3M | $22.4M | -$62.4M | $29.9M | -$437.0M | -$437.0M | $72.8M | $108.8M | $103.4M | $109.0M | $115.2M | $109.0M | $104.7M |
| EPS (Basic) | -$0.54 | $0.30 | $3.05 | $0.47 | -$1.03 | - | - | - | - | $1.06 | $1.76 | $1.72 | $1.82 | $1.76 | $1.68 |
| EPS (Diluted) | -$0.53 | $0.29 | $2.94 | $0.47 | -$1.03 | -$1.03 | -$7.28 | $1.76 | $1.65 | $1.06 | $1.76 | $1.72 | $1.81 | $1.75 | $1.67 |
| Shares Outstanding | 77.2M | 76.5M | 76.3M | 75.4M | 73.5M | 62.8M | 61.5M | 61.5M | 61.0M | 62.8M | 63.1M | 63.1M | 63.3M | 63.4M | 63.4M |
| Gross Margin | - | 82.8% | 83.3% | 18.4% | 12.3% | 15.1% | 11.4% | 11.4% | 12.6% | 12.2% | 12.4% | 10.4% | 9.9% | 10.4% | 10.1% |
| Operating Margin | 1.0% | -8.1% | 5.2% | 1.4% | 0.8% | 2.4% | -3.7% | -3.7% | 1.0% | 2.1% | 2.1% | 2.2% | 2.4% | 2.2% | 2.5% |
| Profit Margin | -39.9% | -13.5% | -1.6% | 0.2% | -0.7% | 0.4% | -4.6% | -4.6% | 0.8% | 1.1% | 1.1% | 1.2% | 1.3% | 1.2% | 1.3% |